BioSpace News Archive

EVERSANA™, the leading independent provider of commercial services to the life science industry, today announced an agreement to acquire Canada-based Cornerstone Research Group, Inc.

Mersana Therapeutics, Inc. announced that it will host a conference call and webcast on Wednesday, November 6, 2019 at 8:00 a.m. ET to report financial results for the third quarter ended September 30, 2019 and provide business updates.

Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that its poster demonstrating positive data from its triple regimen, U.S. Phase 2a study evaluating CC-31244 and sofosbuvir/velpatasvir (Epclusa)

DURECT Corporation announced that it will report third quarter and nine months ended September 30, 2019 financial results and host a conference call after the market close on Monday, November 4, 2019.

Cerus Corporation (Nasdaq: CERS) today announced financial results for the third quarter ended September 30, 2019.

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the third quarter of 2019.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Thursday, October 31, 2019 to release expanded results from its allergen chamber clinical methods trial of topical ocular reproxalap in patients with allergic conjunctivitis and to announce the design of the Phase 3 INVIGORATE clinical trial.

Medicare beneficiaries living in Maine and New Hampshire have access to one of the very few Medicare Advantage contracts in the country to earn 5 out of 5 Stars from the Centers for Medicare and Medicaid Services for 2020.

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced financial results for the third quarter of 2019, updated guidance for the remainder of 2019, and guidance for the full year 2020.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced presentation of real-world data from pediatric users of the t:slim X2™ insulin pump with Basal-IQ® predictive low-glucose suspend technology at the 45th annual conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD).